TNFAIP3 expression was significantly downregulated (p < 0.001, Wilcoxon test) in breast invasive carcinoma (BRCA) and 11 other cancer types, including lung adenocarcinoma (LUAD), colon adenocarcinoma (COAD), and bladder urothelial carcinoma (BLCA). Here, TNFAIP3 is linked to colon adenocarcinoma.